New Delhi, March 1 (IANS) The developer of Covid-19 vaccine Covaxin, Bharat Biotech is considering an initial public offering that could raise over $500 million, according to sources cited by multiple reports.Discussions are underway including key aspects of the proposed share sale, including size and timing, they said.Bharat Biotech plans Rs 200–250 crore of capital expenditure in FY26 for a large vaccine manufacturing facility being developed under Sapigen Biologix Pvt Ltd in Bhubaneswar, Od…
Trending
- Tumbadchi Manjula (2026) Movie Review: A Delightful Marathi Comedy That Wins Hearts With Its Village Charm
- Mollywood Times (2026) Review: Naslen Shines in a Bold, Bittersweet Love-Hate Letter to Malayalam Cinema
- Sannidhanam P.O. Movie Review: A Devotional Drama That Speaks From the Heart
- The Pyramid Scheme Exposes the Fast-Money Dreams Destroying Middle-Class India
- Brown (2026) Review: Karisma Kapoor Delivers a Career-Defining Performance in This Hauntingly Beautiful Zee5 Crime Drama
- Gullak Season 5 Review: The Mishras Are Back and More Heartwarming Than Ever
- Mango Pachcha Review (2026): A Gritty Crime Drama That Hits Close to Home
- Peddi (2026) Movie Review: Ram Charan’s Career-Best Performance Powers a Stirring Tale of Grit, Identity and Belonging